New scanner prototypes aim to improve brain bleed surgery

NCT ID NCT07455201

Recruiting now Knowledge-focused Sponsor: Icahn School of Medicine at Mount Sinai Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests two new Siemens imaging prototypes during minimally invasive surgery to remove brain bleeds. The tools aim to detect leftover bleeding and measure blood flow in the brain. Researchers will compare the prototype images with standard CT scans to see if they are useful. The study involves 15 adults having surgery at Mount Sinai West Hospital.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this could improve how doctors see leftover bleeding and blood flow after brain bleed surgery, potentially guiding better treatment.
What could go wrong: This is a very small, early feasibility study with only 15 people. The prototypes are still being tested and may not provide clear benefits or change patient outcomes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for INTRACEREBRAL HEMORRHAGE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

intracerebral hemorrhage

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

INTRACEREBRAL HEMORRHAGE

Contacts and locations

Locations

Mount Sinai West
RECRUITING

New York, New York, 10019, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.